Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
screening
Research
Rare EGFR mutation increases lung cancer risk more than smoking
In never-smokers, the risk for developing lung cancer increases by nearly 62 times when harboring the EGFR T790M mutation.
Marissa Russo
Sep 17, 2026 2:00pm
Roche signs $1B Dualitas deal to collab on bispecific screening
Sep 17, 2026 8:07am
AI could spot heart disease in breast cancer mammograms
Mar 9, 2026 2:25pm
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
PacBio launches carrier screening panel in reproductive health
Sep 22, 2025 11:00am
